AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr | ₹82 Cr |
What is the latest Contingent Liabilities ratio of AJANTA PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.12 Cr |
| Mar2024 | ₹4.42 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹6.76 Cr |
| Mar2021 | ₹82 Cr |
How is Contingent Liabilities of AJANTA PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.12 Cr | 83.71 | |
| Mar2024 | ₹4.42 Cr | 9.68 | |
| Mar2023 | ₹4.03 Cr | -40.38 | |
| Mar2022 | ₹6.76 Cr | -91.74 | |
| Mar2021 | ₹82 Cr | - | |
Compare Contingent Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹31,266.2 Cr | -2.9% | 3.9% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2.9% |
3.9% |
-11.6% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses